Towards xenotransplantation: Genetically altered pig kidneys prove viable in non-human primates

Researchers used a genetically engineered porcine donor to develop kidney grafts.

Vanqua raises $45M; Aerovate to look for strategic alternatives

Plus, news about GSK, iTeos, Oxolife and SmallCella: Vanqua Bio reels in $45M: The Chicago neuroscience biotech extended its Series B, a spokesperson confirmed to

July 9, 2024

Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031 – Biotech Investments

Medartis Holding AG / Key word(s): Financing/Issue of Debt 03-Apr-2024 / 17:43 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

April 5, 2024

Guardant posts data for colon cancer blood test amid push from rivals

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Guardant Health shared clinical data on

March 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.